Download Gene Section PTPRG (protein tyrosine phosphatase, receptor type, G)

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Gene Section
Mini Review
PTPRG (protein tyrosine phosphatase, receptor
type, G)
Cornelis P Tensen, Remco van Doorn
Departments of Dermatology and Medical Statistics, Leiden University Medical Center, Leiden, the
Netherlands
Published in Atlas Database: December 2006
Online updated version: http://AtlasGeneticsOncology.org/Genes/PTPRGID41930ch3p21.html
DOI: 10.4267/2042/38408
This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence.
© 2007 Atlas of Genetics and Cytogenetics in Oncology and Haematology
protein contains an extracellular carbonic anhydraselike and fibronectin type III-like domain, a single
transmembrane domain, and a cytoplasmic region with
2 tandem catalytic tyrosine phosphatase domains. Y2H,
animal models.
Identity
Hugo: PTPRG
Other names: HPTPG; PTPG; R-PTP-GAMMA;
RPTPG
Location: 3p14.2
Homology
PTPRG shares a PTP domain, involved in
dephosphorylating phosphorylated tyrosine residues,
with the other receptor-like protein tyrosine
phosphatases. The PTPRG gene is conserved in
vertebrates. The human and mouse (1442-amino acid)
sequences share 95% identity at the amino acid level.
DNA/RNA
Description
The PTPRG gene is composed of 30 exons and is
approximately 780 kb in size.
Transcription
Mutations
The transcript length is 4338 bp. An alternatively
spliced variant has been reported with a transcript
length of 5655 bp.
Germinal
No germline mutations have been reported.
Pseudogene
Somatic
No pseudogenes have been reported.
8 different missense mutations in the PTPRG gene have
been identified in colon carcinomas: C1082T (T361M),
C1385T (A462V), C1541T (T514M), C1777T
(R593W), A2864G (E955G), A2918G (Y973C),
C3934T (R1312W) A3976G (I1326V).
Loss of heterozygosity (LOH) of a region which
includes the PTPRG locus has been shown in clear
renal cell carcinoma, lung carcinoma and colon
carcinoma.
Protein
Description
Amino acids: 1445. Molecular weight: 162058 Daltons.
The PTPRG gene belongs to the receptor class 5
subfamily of the protein-tyrosine phosphatase family.
Expression
PTPRG is expressed in several tissues.
Implicated in
Localisation
Note: PTPRG has been considered a potential tumor
suppressor gene based on its function, antagonizing
activity of protein tyrosine kinases that often function
as oncoproteins. Secondly, because it maps to a region
of human chromosome 3, 3p21, that is frequently
Membrane. Single-pass type I membrane protein.
Function
Involved in regulating signaling through ligandcontrolled protein tyrosine dephosphorylation. The
Atlas Genet Cytogenet Oncol Haematol. 2007;11(2)
107
PTPRG (protein tyrosine phosphatase, receptor type, G)
Tensen CP, van Doorn R
van Doorn R, Zoutman WH, Dijkman R, de Menezes RX,
Commandeur S, Mulder AA, van der Velden PA, Vermeer MH,
Willemze R, Yan PS, Huang TH, Tensen CP. Epigenetic
profiling
of
cutaneous
T-cell
lymphoma:
promoter
hypermethylation of multiple tumor suppressor genes including
BCL7a, PTPRG, and p73. J Clin Oncol 2005;23(17):38863896.
deleted in renal cell carcinoma and Lung carcinoma.
Thirdly, because PTPRG has been shown to harbor
point mutations in a subset of colon carcinomas.
Fourthly, because the PTPRG gene shows promoter
hypermethylation in cutaneous T-cell lymphoma and
melanoma. Finally, lower expression levels of PTPRG
have been reported for a number of cancerous tissues
including gastric cancer.
Furuta J, Nobeyama Y, Umebayashi Y, Otsuka F, Kikuchi K,
Ushijima T. Silencing of Peroxiredoxin 2 and aberrant
methylation of 33 CpG islands in putative promoter regions in
human malignant melanomas. Cancer Res 2006;66(12):60806.
References
Wu CW, Kao HL, Li AF, Chi CW, Lin WC. Protein tyrosinephosphatase expression profiling in gastric cancer tissues.
Cancer Lett 2006;242(1):95-103.
LaForgia S, Morse B, Levy J, Barnea G, Cannizzaro LA, Li F,
Nowell PC, Boghosian-Sell L, Glick J, Weston A, et al.
Receptor protein-tyrosine phosphatase gamma is a candidate
tumor suppressor gene at human chromosome region 3p21.
Proc Natl Acad Sci USA 1991;88(11):5036-5040.
This article should be referenced as such:
Tensen CP, van Doorn R. PTPRG (protein tyrosine
phosphatase, receptor type, G). Atlas Genet Cytogenet Oncol
Haematol.2007;11(2):107-108.
Wang Z, Shen D, Parsons DW, Bardelli A, Sager J, Szabo S,
Ptak J, Silliman N, Peters BA, van der Heijden MS, Parmigiani
G, Yan H, Wang TL, Riggins G, Powell SM, Willson JK,
Markowitz S, Kinzler KW, Vogelstein B, Velculescu VE.
Mutational analysis of the tyrosine phosphatome in colorectal
cancers. Science 2004;304(5674):1164-1166.
Atlas Genet Cytogenet Oncol Haematol. 2007;11(2)
108
Related documents
Gene Section DIRC3 (disrupted in renal carcinoma 3) in Oncology and Haematology
Gene Section DIRC3 (disrupted in renal carcinoma 3) in Oncology and Haematology
Gene Section DIRC1 (disrupted in renal carcinoma 1) in Oncology and Haematology
Gene Section DIRC1 (disrupted in renal carcinoma 1) in Oncology and Haematology
Gene Section MN1 (meningioma 1) Atlas of Genetics and Cytogenetics
Gene Section MN1 (meningioma 1) Atlas of Genetics and Cytogenetics
Cancer Prone Disease Section Rombo syndrome Atlas of Genetics and Cytogenetics
Cancer Prone Disease Section Rombo syndrome Atlas of Genetics and Cytogenetics
Cancer Prone Disease Section WAGR (Wilms' tumor/aniridia/genitourinary anomalies/mental retardation syndrome)
Cancer Prone Disease Section WAGR (Wilms' tumor/aniridia/genitourinary anomalies/mental retardation syndrome)
Cancer Prone Disease Section Trichothiodystrophy (TTD) Atlas of Genetics and Cytogenetics
Cancer Prone Disease Section Trichothiodystrophy (TTD) Atlas of Genetics and Cytogenetics
Leukaemia Section t(8;16)(p11;p13) in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section t(8;16)(p11;p13) in treatment related leukemia Atlas of Genetics and Cytogenetics
Leukaemia Section t(3;17)(q26;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(3;17)(q26;q22) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section NBN (Nijmegen breakage syndrome 1) Atlas of Genetics and Cytogenetics
Gene Section NBN (Nijmegen breakage syndrome 1) Atlas of Genetics and Cytogenetics
Gene Section DIRC2 (disrupted in renal carcinoma 2) in Oncology and Haematology
Gene Section DIRC2 (disrupted in renal carcinoma 2) in Oncology and Haematology
Leukaemia Section t(7;12)(q36;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Leukaemia Section t(7;12)(q36;p13) Atlas of Genetics and Cytogenetics in Oncology and Haematology
Gene Section PLAG1 (Pleomorphic adenoma gene 1) Atlas of Genetics and Cytogenetics
Gene Section PLAG1 (Pleomorphic adenoma gene 1) Atlas of Genetics and Cytogenetics
Publikationen in Top-Journalen (Impact > 6.0) in letzten 10 Jahren
Publikationen in Top-Journalen (Impact > 6.0) in letzten 10 Jahren
51. Arrington CB, Patel A, Bacino CA, et al. Haploinsufficiency of the
51. Arrington CB, Patel A, Bacino CA, et al. Haploinsufficiency of the
Infer mRNA from protein
Infer mRNA from protein
Presentation
Presentation
Cancer Prone Disease Section Multiple osteochondromas (MO) Atlas of Genetics and Cytogenetics
Cancer Prone Disease Section Multiple osteochondromas (MO) Atlas of Genetics and Cytogenetics
Hidden genetic variation - Wageningen UR E
Hidden genetic variation - Wageningen UR E
study of genomic alterations in colon carcinoma by array
study of genomic alterations in colon carcinoma by array
The human genome and the chromosomal basis of heredity
The human genome and the chromosomal basis of heredity
HT + RT + CT - Scienty Med
HT + RT + CT - Scienty Med
Assignment 10 - Ga naar Edurep Delen
Assignment 10 - Ga naar Edurep Delen